Genpact CAO awarded 6,802 restricted share units

Genpact Limited’s Chief Accounting Officer, Anthony J. Radesca, received an equity grant of 6,802 common shares on January 30, 2026, at a price of $0 per share.

Rhea-AI Filing Summary

Genpact Limited’s Chief Accounting Officer, Anthony J. Radesca, received an equity grant of 6,802 common shares on January 30, 2026, at a price of $0 per share. The award is in the form of restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Each RSU converts into one Genpact common share upon vesting. One-third of the shares will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, contingent on his continued service. Following this grant, he beneficially owns 26,868 common shares directly.

Insider Trade Summary

Grant/Award: 6,802 shares

Grant/Award 1 txn

Insider Radesca Anthony J.

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	6,802	$0.00	$0.00

Holdings After Transaction: Common Shares — 26,868 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

FAQ

What insider transaction did Genpact (G) report for Anthony J. Radesca?

Genpact reported that Chief Accounting Officer Anthony J. Radesca received 6,802 restricted share units on January 30, 2026, at a price of $0 per share. The award was granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, increasing his beneficial ownership to 26,868 common shares.

How many Genpact (G) shares does Anthony J. Radesca own after this grant?

After the reported equity grant, Anthony J. Radesca beneficially owns 26,868 Genpact common shares directly. This total includes the 6,802 restricted share units awarded on January 30, 2026, which convert into common shares as they vest over the stated three-year schedule.

What are the vesting terms of the 6,802 RSUs granted by Genpact (G)?

The 6,802 restricted share units vest in three equal installments. One-third of the underlying shares will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029. Vesting is conditioned on Anthony J. Radesca’s continued service through each applicable vesting date.

What does each RSU granted to Genpact (G) executive Anthony J. Radesca represent?

Each restricted share unit awarded to Anthony J. Radesca represents the right to receive one Genpact Limited common share upon vesting. These RSUs were granted under the company’s 2017 Omnibus Incentive Compensation Plan as part of his equity-based incentive package, subject to the vesting schedule.

Was cash paid for the Genpact (G) RSUs awarded to Anthony J. Radesca?

No cash was paid per share for this award. The filing shows 6,802 common shares acquired at a price of $0 per share, reflecting an equity-based grant rather than an open-market purchase, granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Is the Genpact (G) RSU grant to Anthony J. Radesca a direct holding?

Yes, the filing classifies the 6,802-share RSU award as a direct holding. After this grant, Anthony J. Radesca is reported to beneficially own a total of 26,868 Genpact common shares directly, with vesting of the RSUs occurring over three specified future dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Radesca Anthony J.

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/30/2026		A		6,802(1)	A	$0	26,868	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Anthony J. Radesca	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.